Episode

Aspirin Plus Anticoagulation: What Are the Risks? - Frankly Speaking Ep 465

Podcast
Frankly Speaking About Family Medicine
Published
Dec 29, 2025
Duration seconds
645
Processing state
not_requested
Canonical source
https://primedfranklyspeaking.podbean.com/e/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465/
Audio
https://mcdn.podbean.com/mf/web/ieqiy8ek4quvj7qn/frankly-speaking-ep-465-afib-anticoagulant.mp4
JSON
/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465
Markdown
/podcast/frankly-speaking-about-family-medicine-434006/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/aspirin-plus-anticoagulation-what-are-the-risks-frankly-speaking-ep-465.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465 Overview: Many patients with coronary artery disease take aspirin, but how should clinicians navigate management when an anticoagulant is also needed? In this episode, we review indications for therapy, explore evidence on dual use, and discuss how to counsel patients on balancing cardiovascular benefits with the risks of combination therapy. Episode resource links: Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. Published online August 31, 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2507532 Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected]